Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation
Pharmaceutical Investing EyePoint Pharmaceuticals Strengthens Global IP with Notices of Allowance for Two U.S. Patents Related to DEXYCU™
Medical Device Investing U.S. Patent and Trademark Office has granted to Todos Medical two additional patents
Nanotech Investing Nano Dimension Receives Patent Approval from U.S. Patent and Trademark Office for Innovative Print-Head Maintenance System
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
